Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Arch Oral Biol ; 108: 104547, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31525531

ABSTRACT

OBJECTIVE: This study investigated the risk and prognostic value of single nucleotide polymorphisms (SNP) inIL-8, MMP-1 and MMP-13 in oral and oropharyngeal squamous cell carcinomas (SCCs). DESIGN: SNPs rs2227532 and rs4073 inIL-8, rs2071230 and rs470558 in MMP-1, and rs2252070 in MMP-13 were genotyped in 125 oral and oropharyngeal SCC patients and 130 healthy controls, using TaqMan allelic discrimination assays. Multiple logistic regression models were used to explore the association between SNPs and cancer development, as well as SNP-SNP interaction and gene-environmental factor (GxE) interaction. Univariate and multivariate methods were applied for survival analyses. RESULTS: With exception of rs2227532, all the SNPs were in Hardy-Weinberg equilibrium in the control. No associations between rs4073 in IL-8 and rs2071230 and rs470558 in MMP-1 were observed, but rs2252070 in MMP-13, in the dominant model, was associated in a protective manner to oral and oropharyngeal SCC (OR: 0.20, 95% CI: 0.06-0.71, p = 0.007). All SNPs interact significantly with cigarette smoking and alcohol consumption on susceptibility to oral and oropharyngeal SCC, but they showed no influence on survival of the patients. CONCLUSIONS: Our results show that rs2252070 inMMP-13 may confer protection effect against oral and oropharyngeal SCC. In addition, the combined effects of IL-8 (rs4073), MMP-1 (rs2071230 and rs470558) and MMP-13 (rs2252070) with environmental carcinogens, such as tobacco and alcohol, are related to increased risk for oral and oropharyngeal SCC development.


Subject(s)
Carcinoma, Squamous Cell , Interleukin-8 , Matrix Metalloproteinase 13 , Matrix Metalloproteinase 1 , Mouth Neoplasms , Carcinogens/toxicity , Carcinoma, Squamous Cell/genetics , Genetic Predisposition to Disease , Humans , Interleukin-8/genetics , Matrix Metalloproteinase 1/genetics , Matrix Metalloproteinase 13/genetics , Mouth Neoplasms/genetics , Polymorphism, Single Nucleotide , Prognosis
2.
Oral Dis ; 25(1): 54-63, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30033552

ABSTRACT

BACKGROUND: This study investigated the influence of single nucleotide polymorphisms (SNP) in RAD51 and XRCC3 on susceptibility to oral and oropharyngeal squamous cell carcinomas (SCC) and determined their clinicopathological significance. SUBJECTS AND METHODS: SNPs rs1801320 and rs1801321 in RAD51 and rs861539 in XRCC3 were genotyped in 81 patients presenting oral SCC, 45 presenting oropharyngeal SCC, and 130 healthy controls, using TaqMan allelic discrimination assays. Multiple logistic regression models were used to explore the association between SNPs and cancer development, as well as gene-gene (GxG) interaction and gene-environmental factor (GxE) interaction. Clinicopathological associations were verified through the chi-square test, and univariate and multivariate methods were applied for survival analyses. RESULTS: Although allelic and genotypic models and the GxG interaction analysis were nonsignificant, the GxE analysis revealed synergistic effects of the risk alleles of rs1801320, rs1801321, and rs861539 with smoking and alcohol consumption on susceptibility to oral and oropharyngeal SCC. Furthermore, oropharyngeal SCC patients carrying the XRCC3 rs861539 GT/TT genotype (T risk allele) presented a shorter overall survival than GG genotype carriers. CONCLUSION: Combined effects of RAD51 (rs1801320 and rs1801321) and XRCC3 (rs861539) SNPs with environmental carcinogens (tobacco and alcohol) are associated with oral and oropharyngeal SCC development.


Subject(s)
Carcinoma, Squamous Cell/genetics , DNA-Binding Proteins/genetics , Genetic Predisposition to Disease , Oropharyngeal Neoplasms/genetics , Polymorphism, Single Nucleotide , Rad51 Recombinase/genetics , Alcohol Drinking/adverse effects , Alleles , Carcinoma/genetics , Case-Control Studies , Genotype , Humans , Risk Factors , Smoking/adverse effects
3.
Int. j. odontostomatol. (Print) ; 12(2): 125-130, jun. 2018. tab, graf
Article in English | LILACS | ID: biblio-954253

ABSTRACT

ABSTRACT: Multiple salivary gland tumors represent an unusual event characterized by the development of composite lesions originated from minor or major salivary glands. These neoplasms can be categorized into three perspectives: Histologic type, time of appearance and topographic distribution. We report an unusual case of a 73-year-old black man with an acinic cell carcinoma (ACC) of the oral mucosa discovered incidentally during surgical removal of an adjacent mucocele. Approximately one year after the first consultation, the patient was seen at the local cancer reference center with a third lesion that was diagnosed as an adenoid cystic carcinoma (AdCC) of the upper lip. The patient underwent surgical reconstruction of the treated areas and has been free of the disease for the past year. To our knowledge, the combination of ACC and AdCC in intraoral sites has not been reported in the literature.


RESUMEN: Los tumores de glándulas salivales múltiples representan un evento inusual caracterizado por el desarrollo de lesiones compuestas, originadas en glándulas salivales menores o mayores. Estos neoplasmas se pueden categorizar en tres perspectivas: tipo histológico, tiempo de aparición y distribución topográfica. Reportamos un caso inusual de un hombre negro de 73 años con un carcinoma de célula acínica (ACC) de la mucosa oral descubierta incidentalmente durante la extirpación quirúrgica de un mucocele adyacente. Aproximadamente un año después de la primera consulta, el paciente se presentó en el centro de referencia del cáncer local con una tercera lesión que fue diagnosticada como carcinoma adenoide quístico (AdCC) del labio superior. El paciente se sometió a la reconstrucción quirúrgica de las áreas tratadas y durante el último año no ha presentado recurrencia de la enfermedad. De acuerdo a nuestro conocimiento la combinación de ACC y AdCC en sitios intraorales no se ha informado en la literatura.


Subject(s)
Humans , Male , Aged , Salivary Gland Neoplasms/pathology , Neoplasms, Second Primary/mortality , Carcinoma, Acinar Cell/pathology , Carcinoma, Adenoid Cystic/surgery , Radiotherapy , Biopsy , Salivary Gland Neoplasms/therapy , Carcinoma, Acinar Cell/therapy , Lip
4.
Natal; s.n; fev. 2016. 105 p. ilus, tab, graf. (BR).
Thesis in Portuguese | LILACS, BBO - Dentistry | ID: biblio-867988

ABSTRACT

Falhas nos genes responsáveis por reparos no DNA podem influenciar no surgimento de câncer ou afetar a resposta aos tratamentos. Estudos têm demonstrado que a variação na capacidade de reparo do DNA pode ser resultado de polimorfismos funcionais nestes genes, e alguns destes experimentos sugerem que a presença de polimorfismos de nucleotídeos simples (SNPs), em genes de reparo, está relacionada ao desenvolvimento e resposta ao tratamento de vários cânceres, incluindo o Carcinoma Epidermoide Oral (CEO) e o Carcinoma Epidermoide de Orofaringe (CEOR). Nesta pesquisa avaliou-se a frequência de três SNPs em dois genes de reparo do DNA RAD51 172G>T (c.-61 G>T, rs1801321), RAD51 135G>C (c.-98 G>C, rs1801320) e XRCC3 T241M (c. 722 C>T, rs861539) em indivíduos saudáveis (n=130) e indivíduos com CEO e CEOR (n=126) e investigou-se possíveis relações de tais achados com os desfechos clínicos: resposta tumoral ao tratamento com radioterapia e quimioterapia, recidiva, e sobrevida global. Constatou-se frequência alélica e genotípica em equilíbrio. A presença dos SNPs analisados não revelou ser um fator de risco para o desenvolvimento de CEO ou CEOR; contudo, quando associado ao hábito de fumar ou beber, aumentou o risco de desenvolver o câncer de três a cento e cinquenta vezes (p<000,1). A resposta tumoral ao tratamento de radioterapia e quimioterapia foi semelhante nos pacientes com ou sem SNPs. Nenhum polimorfismo demonstrou significância estatística em relação à sobrevida livre de recidiva ou sobrevida global. Os genótipos AA e AC do SNP rs861539 no gene XRCC3, os genótipos CC e CG do SNP rs1801320 e GG e GT do SNP 1801321 no gene RAD51, aumentam o risco do desenvolvimento de carcinoma epidermoide oral e de orofaringe, quando associados ao hábito de beber ou fumar. Os polimorfismos estudados nos genes XRCC3 e RAD51 não estão associados à resposta à radioterapia, sobrevida livre de recidiva ou sobrevida global


Faults in the genes responsible for repairs to the DNA can influence the onset of cancer or affect the response to treatment. This research evaluated the frequency of three single nucleotide polymorphisms (SNPs) in two repair genes DNA RAD51 172g> T (rs1801321), RAD51 135G> C (rs1801320) and XRCC3 T241M (rs861539) in individuals without cancer (n = 130) and patients with oral squamous cell carcinoma (OSC) and carcinoma oropharyngeal squamous (ORSC) (n = 126) and investigated possible relationships of these findings with clinical and pathological data and clinical outcomes: tumor response to radiotherapy and chemotherapy, disease-free survival, and overall survival. It was found that the allele and genotype frequencies were in equilibrium Hard-Weinberg equilibrium. The presence of at least one polymorphic allele in XRCC3 (rs861539) gene is associated with histological grade (WHO) higher (p = 0.007). We observed a higher recurrence rate trend (p = 0.08) and more advanced stage (p = 0.08) in the group that had at least one polymorphic allele of RAD51 gene (rs1801321). The presence of the analyzed SNPs not proved to be a risk factor for the development of CEO or CEOR; however, when combined with smoking or drinking, increased the risk of developing cancer from three to one hundred and fifty times. The tumor response to radiotherapy and chemotherapy was similar in patients with and without SNPs. No polymorphism showed statistical significance in relation to recurrence-free survival or overall survival. We conclude that the presence of at least one polymorphic allele of the SNPs rs861539 in XRCC3 gene, rs1801320 and rs1801321 in the RAD51 gene increase the risk of development of OSC and ORSC, when associated with the habit of drinking or smoking. Polymorphisms studied in XRCC3 and RAD51 genes are not associated with response to radiation therapy, relapse-free survival or overall survival


Subject(s)
Humans , Male , Female , Carcinoma, Squamous Cell/surgery , Carcinoma, Squamous Cell/radiotherapy , Oropharyngeal Neoplasms/pathology , Polymorphism, Single Nucleotide/immunology , Prognosis , DNA Repair , Survival Analysis , Brazil , Chi-Square Distribution , Longitudinal Studies , Logistic Models
5.
Int. j. odontostomatol. (Print) ; 9(2): 307-312, ago. 2015. ilus
Article in English | LILACS | ID: lil-764046

ABSTRACT

Metastatic lesions to the mandible may be originated from primary tumors elsewhere in the body. However, metastatic colonic carcinomas to this bone have been described infrequently. We report the case of a 71-year-old man with an adenocarcinoma in the sigmoid colon with liver metastasis. The patient underwent chemotherapy with indication of sigmoidectomy and retroperitoneal lymphadenectomy. One year and four months after the first metastatic diagnosis, the patient presented a tumor mass in the body and branch of the right mandible. Histopathological and immunohistochemical analysis with monoclonal antibodies specific for CEA, CK20, CDX-2, and vilin were compatible with the diagnosis of moderately differentiated metastatic adenocarcinoma with colonic origin. However, due to the wide spread of the disease, the patient died four months later. Tumor markers have been applied in clinical practice to assist in the diagnosis and to help guide prognosis, staging and treatment of cancer. The management of metastatic lesions remains a controversial issue and the development of new and more specific markers of gastrointestinal differentiation that may promote early diagnosis, are of continuous interest.


Las lesiones metastásicas de la mandíbula pueden surgir de los tumores primarios en cualquier partes del cuerpo. Sin embargo, el carcinoma metastásico de colon de este hueso se han reportado con poca frecuencia. Presentamos el caso de un hombre de 71 años de edad, con un adenocarcinoma de colon sigmoide con metástasis en el hígado. El paciente fue sometido a quimioterapia con indicación de sigmoidectomía y linfadenectomía retroperitoneal. Un año y cuatro meses después de la emisión del primer diagnóstico de la metástasis, el paciente presentaba una masa tumoral en el cuerpo y rama de la mandíbula derecha. El análisis histopatológico e inmunohistoquímico con anticuerpos monoclonales específicos para CEA, CK20, CDX-2, y vilin fueron compatibles con el diagnóstico de adenocarcinoma moderadamente diferenciado metastásico originario en el colon. Sin embargo, debido a la amplia propagación de la enfermedad, el paciente murió cuatro meses más tarde. Los marcadores tumorales se han aplicado en la práctica clínica para ayudar en el diagnóstico y ayudar a orientar el pronóstico, la estadificación y tratamiento del cáncer. Gestión de las lesiones metastásicas sigue siendo un tema controvertido, y el desarrollo de marcadores nuevos y específicos que promueven la diferenciación del diagnóstico precoz gastrointestinal, son de interés continuo.


Subject(s)
Humans , Male , Aged , Adenocarcinoma/pathology , Mandibular Neoplasms/secondary , Colonic Neoplasms/pathology , Immunohistochemistry , Liver Neoplasms/secondary
SELECTION OF CITATIONS
SEARCH DETAIL
...